Related references
Note: Only part of the references are listed.A single mutation on the human amyloid polypeptide modulates fibril growth and affects the mechanism of amyloid-induced membrane damage
Anais R. F. Hoffmann et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2018)
Fundamentals of travelling wave ion mobility revisited: I. Smoothly moving waves
K. Richardson et al.
INTERNATIONAL JOURNAL OF MASS SPECTROMETRY (2018)
Time dependence of NMR observables reveals salient differences in the accumulation of early aggregated species between human islet amyloid polypeptide and amyloid-β
Anai S. R. F. Hoffmann et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2018)
A capillary zone electrophoresis method to investigate the oligomerization of the human Islet Amyloid Polypeptide involved in Type 2 Diabetes
Corentin Berardet et al.
JOURNAL OF CHROMATOGRAPHY A (2018)
Monitoring Conformational Landscape of Ovine Prion Protein Monomer Using Ion Mobility Coupled to Mass Spectrometry
Guillaume Van der Rest et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2017)
Size Exclusion Chromatography-Ion Mobility-Mass Spectrometry Coupling: a Step Toward Structural Biology
Guillaume Van der Rest et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2017)
Effects of Protein Corona on IAPP Amyloid Aggregation, Fibril Remodelling, and Cytotoxicity
Emily H. Pilkington et al.
SCIENTIFIC REPORTS (2017)
Thioflavin T fluorescence to analyse amyloid formation kinetics: Measurement frequency as a factor explaining irreproducibility
Mathew Sebastiao et al.
ANALYTICAL BIOCHEMISTRY (2017)
Inhibition of islet amyloid polypeptide aggregation and associated cytotoxicity by nonsteroidal anti-inflammatory drugs
Jessica S. Fortin et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2016)
ESI-IMS-MS: A method for rapid analysis of protein aggregation and its inhibition by small molecules
Lydia M. Young et al.
METHODS (2016)
Influence of trehalose on human islet amyloid polypeptide fibrillation and aggregation
Cong-Heng Chen et al.
RSC ADVANCES (2016)
Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics
Andisheh Abedini et al.
ELIFE (2016)
Rapid Assessment of Human Amylin Aggregation and Its Inhibition by Copper(II) Ions by Laser Ablation Electrospray Ionization Mass Spectrometry with Ion Mobility Separation
Hang Li et al.
ANALYTICAL CHEMISTRY (2015)
On the structure of the copper-amylin complex
Isabel Riba et al.
INTERNATIONAL JOURNAL OF MASS SPECTROMETRY (2015)
Mechanistic Contributions of Biological Cofactors in Islet Amyloid Polypeptide Amyloidogenesis
Phuong Trang Nguyen et al.
JOURNAL OF DIABETES RESEARCH (2015)
Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus
Hye Rin Jeong et al.
CLINICAL INTERVENTIONS IN AGING (2015)
Screening and classifying small-molecule inhibitors of amyloid formation using ion mobility spectrometry-mass spectrometry
Lydia M. Young et al.
NATURE CHEMISTRY (2015)
Studies of Polymorphism of Amyloid-beta(42) Peptide from Different Suppliers
Mariya Yu. Suvorina et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
In Search of Aggregation Pathways of IAPP and Other Amyloidogenic Proteins: Finding Answers through NMR Spectroscopy
Hiren R. Patel et al.
JOURNAL OF PHYSICAL CHEMISTRY LETTERS (2014)
Ion Mobility Spectrometry-Mass Spectrometry Defines the Oligomeric Intermediates in Amylin Amyloid Formation and the Mode of Action of Inhibitors
Lydia M. Young et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Apoptosis induced by islet amyloid polypeptide soluble oligomers is neutralized by diabetes-associated specific antibodies
Yaron Bram et al.
SCIENTIFIC REPORTS (2014)
Bisphenol A Accelerates Toxic Amyloid Formation of Human Islet Amyloid Polypeptide: A Possible Link between Bisphenol A Exposure and Type 2 Diabetes
Hao Gong et al.
PLOS ONE (2013)
Amylin Uncovered: A Review on the Polypeptide Responsible for Type II Diabetes
Karen Pillay et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Silibinin inhibits the toxic aggregation of human islet amyloid polypeptide
Biao Cheng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Alternative Pathways of Human Islet Amyloid Polypeptide Aggregation Distinguished by 19F Nuclear Magnetic Resonance-Detected Kinetics of Monomer Consumption
Yuta Suzuki et al.
BIOCHEMISTRY (2012)
Ionic Strength Effects on Amyloid Formation by Amylin Are a Complicated Interplay among Debye Screening, Ion Selectivity, and Hofmeister Effects
Peter J. Marek et al.
BIOCHEMISTRY (2012)
Fibril Structure of Human Islet Amyloid Polypeptide
Sahar Bedrood et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The Amyloid Formation Mechanism in Human IAPP: Dimers Have β-Strand Monomer-Monomer Interfaces
Nicholas F. Dupuis et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis
Leena Haataja et al.
ENDOCRINE REVIEWS (2008)
Simultaneous analysis by capillary electrophoresis of five amyloid peptides as potential biomarkers of Alzheimer's disease
Romain Verpillot et al.
JOURNAL OF CHROMATOGRAPHY A (2008)
Mechanism of thioflavin T binding to amyloid fibrils
R Khurana et al.
JOURNAL OF STRUCTURAL BIOLOGY (2005)
Analysis of the structural and functional elements of the minimal active fragment of islet amyloid polypeptide (IAPP) - An experimental support for the key role of the phenylalanine residue in amyloid formation
R Azriel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Processing of synthetic pro-islet amyloid polypeptide (proIAPP) 'amylin' by recombinant prohormone convertase enzymes, PC2 and PC3, in vitro
CE Higham et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Share Paper
